Signum Surgical develops colorectal medical devices, centered on its FDA De Novo-authorized BioHealx Anal Fistula Device for minimally invasive closure of anal fistulas. The company’s distinctive approach uses a bioabsorbable implant to compress the fistula tract from outside the sphincter complex, aiming to support healing without cutting the anal sphincter. Its team brings substantial medtech and colorectal-surgery experience, including co-founder and CTO Eoin Bambury, a named inventor on 56 granted patent filings.
FDA De Novo Clearance
ISO 13485 Certified